Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00237328 · ClinicalTrials.gov registry record

Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

A clinical trial of Thrombosis, sponsored by Duke University.

Completed
Registry status
1,015
Enrollment target
4
Study locations

NCT00237328 is a study of Thrombosis that has completed, run by Duke University. The registered enrollment target is 1,015 participants, above the 434-participant average among 28 other Thrombosis trials with a reported enrollment target (134% higher). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00237328, a study of Thrombosis, has completed, sponsored by Duke University.

COMPLETED
Registry status
1,015 participants
Enrollment target
4
Study locations

Study Summary

Heparin is a drug that is widely used to prevent and treat blood clotting. Individuals undergoing cardiopulmonary bypass surgery are administered high doses of heparin, and some of them develop antibodies to the drug. This immune response can lead to the formation of blood clots, setting the stage for a potential heart attack or stroke. The purpose of this study is to evaluate how often an immune response to heparin leads to the formation of blood clots in individuals who have had heart surgery.

Conditions Studied

Thrombosis

Interventions

  • DRUG Heparin

Study Locations (4)

North Carolina

  • University of North Carolina - Chapel Hill
  • Duke University Medical Center - Durham

Minnesota

  • Mayo Clinic, Rochester - Rochester

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 1,015 participants
Start Date 2006-06
Est. Completion 2012-07

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00237328

The ClinicalTrials.gov registry entry for NCT00237328 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,015 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 434-participant average among 28 other Thrombosis trials with a reported enrollment target (134% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Heparin is the first listed.

NCT00237328 reports 4 study locations spanning 3 distinct geographic areas - top geographies include North Carolina, Minnesota, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00237328 about?

NCT00237328 is a clinical study titled "Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery". Heparin is a drug that is widely used to prevent and treat blood clotting. Individuals undergoing cardiopulmonary bypass surgery are administered high doses of heparin, and some of them develop antibodies to the drug. This immune response can lead to the formation of blood clots, setting the stage f...

What is the current status of trial NCT00237328?

This trial is currently completed. The enrollment target is 1,015 participants. The study started on 2006-06. Estimated completion is 2012-07.

What conditions does trial NCT00237328 study?

This clinical trial studies the following conditions: Thrombosis.

What interventions are being tested in trial NCT00237328?

The interventions under investigation include: Heparin (DRUG).

Who is sponsoring clinical trial NCT00237328?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00237328 being conducted?

This trial has 4 study locations across Minnesota, North Carolina, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Thrombosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Thrombosis

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.